CoreCivic sells Kansas ICE prison to the feds as activists allege medical neglect
CoreCivic said it sold its Kansas ICE detention facility in Leavenworth to the U.S. Department of Homeland Security for $238.4 million, about five months after Leavenworth approved reopening. CoreCivic expects to keep operating the 1,033-bed site under its ICE contract, but said it cannot assure future terms. The city and activists raised concerns about medical neglect; CoreCivic and DHS denied them.
How this was made

The 30-second read
Why it matters
The DHS purchase is a new, deal-level event for CoreCivic, but the article frames it alongside allegations of medical neglect, understaffing, and barriers to legal access, plus CoreCivic’s denial and DHS’s counterclaims about detainee healthcare.
Market read
A $238.4 million DHS purchase of a CoreCivic-operated ICE detention facility is a fresh corporate transaction, but the investment case is clouded by renewed allegations and ongoing litigation risk.
What to watch
The article does not specify whether the sale changes performance obligations, pricing, or renewal terms; traders should watch for any subsequent contract amendments or DHS/ICE operational directives tied to the ownership change.
Background
CoreCivic reopened a shuttered Leavenworth prison as an ICE immigrant detention center after the city granted permission, including a community relations advisory board to monitor operating standards.
Ticker impact
CoreCivic sold the 1,033-bed Leavenworth ICE detention facility to DHS for $238.4 million while saying it will keep operating under the existing contract for now.
Likely modest, two-sided reaction: deal supports revenue continuity, but activist and lawsuit overhang may cap upside.
The article discloses a specific $238.4 million sale and states CoreCivic expects to continue operating under the existing ICE contract, but it also highlights reputational and legal risk and provides no new financial guidance or contract economics beyond the sale price.
Market effects
Reinforces that private prison operators remain active in ICE detention asset transfers, but scrutiny over care standards can increase headline and litigation risk across the sector.
Leavenworth oversight concerns may drive local political and legal attention, potentially affecting future permitting and contract renewal dynamics.
Limited, as the transaction is US federal detention contracting with no direct cross-border implications described.
Counterpoint
The sale may be largely administrative, with CoreCivic continuing to operate under existing ICE terms, so the market may treat it as less material than activists claim.
Key entities
- companyCoreCivic
Private prison operator that sold the Leavenworth ICE detention facility to DHS and said it will continue operating under the existing ICE contract for now.
- government_agencyU.S. Department of Homeland Security
Buyer of the Leavenworth detention facility; provided a general statement about ICE arrests and detainee medical care standards.
- government_agencyImmigration and Customs Enforcement (ICE)
Federal detention authority under whose contract CoreCivic says it will continue operating the facility.
- municipalityLeavenworth, Kansas
City that approved the prison’s reopening and is reviewing how the ownership change affects the Special Use Permit and Performance Agreement.



